A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is
Designing an optimized pharmaceutical drug development process is an important problem in itself and is of signi® cant practical and research interest. Drug development lead time is a critical performance metric for a pharmaceutical company. In this paper, we develop a multiclass queueing network model to capture the project dynamics in drug development organizations that involve multiple, concurrent projects with contention for human/technical resources. We explore how drug development leaddoi:10.1080/00207540010004304 fatcat:3ldnv3u4orf7lneugmfdoqaahi